[No author listed] (2000). JCAHO issues revised restraint standards. Hosp Peer Rev. 25, 73–74.Google Scholar

Allen, M. H., Currier, G. W., Carpenter, D., et al. (2001). The expert consensus guideline series. Treatment of behavioral emergencies. Postgrad Med. (Spec No.), 1–88.Google Scholar

Allen, M. H., Currier, G. W., Hughes, D. H., et al. (2005). The expert consensus guideline series. Treatment of behavioral emergencies 2005. J Psychiatr Pract. 11 Suppl 1, 5–108.Google Scholar

American Psychiatric Association (APA) (2013). Diagnostic and Statistical Manual of Mental Disorders. DSM-5, 5th Ed. Arlington, VA: American Psychiatric Association.Google Scholar

Balfour, M. (2014). Reducing restraints and coercion in Dallas via Project BETA. Presentation at American Psychiatric Association Institute for Psychiatric Services Conference, October 30, 2014.Google Scholar

Battaglia, J., Moss, S., Rush, J., et al. (1997). Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study. Am J Emerg Med. 15, 335–340.Google Scholar

Canadian Agency for Drugs and Technologies in Health (CADTH). (2015). Use of antipsychotics and/or benzodiazepines as rapid tranquilization in in-patients of mental facilities and emergency departments: a review of the clinical effectiveness and guidelines. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health. Available at: https://www.cadth.ca/sites/default/files/pdf/htis/oct-2015/RC0718%20Antipsychotics%20for%20rapid%20tranq%20Final.pdf (Accessed May 27, 2016).Google Scholar

Cole, R. (2014). Reducing restraint use in a trauma center emergency room. Nurs Clin North Am. 49, 371–381.Google Scholar

Downey, L. V., Zun, L. S., and Gonzales, S. J. (2007). Frequency of alternative to restraints and seclusion and uses of agitation reduction techniques in the emergency department. Gen Hosp Psychiatry. 29, 470–474.CrossRefGoogle ScholarPubMed

Duc, N. and Maurel, H. (1953). [Treatment of psychomotor agitation with lithium]. Concours Med. 75, 1817–1820.Google ScholarPubMed

Forster, P. L., Cavness, C., and Phelps, M. A. (1999). Staff training decreases use of seclusion and restraint in an acute psychiatric hospital. Arch Psychiatr Nurs. 13, 269–271.Google Scholar

Garriga, M., Pacchiarotti, I., Kasper, S., et al. (2016). Assessment and management of agitation in psychiatry: expert consensus. World J Biol Psychiatry. 17, 86–128.Google Scholar

Holloman, G. H. Jr. and Zeller, S. L. (2012). Overview of Project BETA: best practices in evaluation and treatment of agitation. West J Emerg Med. 13, 1–2.CrossRefGoogle ScholarPubMed

Joint Commission on Accreditation of Healthcare Organizations (1999). Restraint Use Task Force Meeting: Agenda and Materials, May 26, 1999.Google Scholar

Kleiss, E. (1951). [Treatment of psychogenic states of agitation]. Dtsch Med J. 2, 526.Google Scholar

Knox, D. K. and Holloman, G. H. (2012). Use and avoidance of seclusion and restraint: consensus statement of the American Association for Emergency Psychiatry Project BETA Seclusion and Restraint Workgroup. West J Emerg Med. 13, 35–40.Google Scholar

Kohn, D. (1999). CBS News. Detailed report about 60 Minutes II broadcast in 1999 about Charter Health System and restraints. Available at: http://www.cbsnews.com/news/unsafe-haven/ (Accessed May 27, 2016).Google Scholar

Lesem, M. D., et al. (2001). Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients. J Clin Psychiatry. 62, 12–18.CrossRefGoogle ScholarPubMed

Longtin, Y., Sax, H., Leape, L. L., Sheridan, S. E., Donaldson, L., and Pittet, D. (2010). Patient participation: current knowledge and applicability to patient safety. Mayo Clin Proceed. 85, 53–62.CrossRefGoogle ScholarPubMed

McBeth, S. (2004). Get a firmer grasp on restraints. Nurs Manage. 35, 20, 22.CrossRefGoogle ScholarPubMed

Nordstrom, K., Zun, L. S., Wilson, M. P., et al. (2012). Medical evaluation and triage of the agitated patient: consensus statement of the American Association for Emergency Psychiatry Project BETA Medical Evaluation Workgroup. West J Emerg Med. 13, 3–10.CrossRefGoogle Scholar

Prior, H. J. and Lawrance, G. (1952). Agitated melancholia. Med J Aust. 1, 123–124.Google Scholar

Rettig, J. H. (1955). Chlorpromazine for the control of psychomotor excitement in the mentally deficient: a preliminary study. J Nerv Ment Dis. 122, 190–194.CrossRefGoogle ScholarPubMed

Richmond, J. S., Berlin, J. S., Fishkind, A. B., et al. (2012). Verbal de-escalation of the agitated patient: consensus statement of the American Association for Emergency Psychiatry Project BETA De-escalation Workgroup. West J Emerg Med. 13, 17–25.CrossRefGoogle Scholar

Sanford, M. and Scott, L. J. (2008). Intramuscular aripiprazole: a review of its use in the management of agitation in schizophrenia and bipolar I disorder. CNS Drugs. 22, 335–352.Google Scholar

Stowell, K. R., Florence, P., Harman, H. J., and Glick, R. L. (2012). Psychiatric evaluation of the agitated patient: consensus statement of the American Association for Emergency Psychiatry Project BETA Psychiatric Evaluation Workgroup. West J Emerg Med. 13, 11–16.Google Scholar

Talsma, J. (2014). First orally inhaled drug available for agitation in schizophrenia, bipolar disorder. Drug Topics. March 6, 2014. Available at: http://drugtopics.modernmedicine.com/drug-topics/content/tags/adasuve/first-orally-inhaled-drug-available-agitation-schizophrenia-bipolar (Accessed May 30, 2016).Google Scholar

Teulie, M., et al. (1955). [Study of the action of lithium salts in states of psychomotor excitation]. Encephale. 44, 266–285.Google Scholar

U.S. General Accounting Office (GAO). (1999). Mental Health: Improper Restraints and Seclusion Use Places People at Risk. GAO/HEHS-99–176. Washington, DC, U.S. General Accounting Office. Available at: http://surveyor.vo.llnwd.net/o45/data/1039/GAO_and_restraints_he99176.pdf (Accessed May 30, 2016).Google Scholar

Wagstaff, A. J., Easton, J., and Scott, L. J. (2005). Intramuscular olanzapine: a review of its use in the management of acute agitation. CNS Drugs. 19, 147–164.Google Scholar

Weiss, E. M., et al. (1998). Deadly restraint: a Hartford Courant investigative report. Hartford Courant. October 11–15.Google Scholar

Wilson, M. P., Minassian, A., Bahramzi, M., Campillo, A., and Vilke, G. M. (2014). Despite expert recommendations, second-generation antipsychotics are not often prescribed in the emergency department. J Emerg Med. 46, 808–813.CrossRefGoogle Scholar

Wilson, M. P., Pepper, D., Currier, G. W., Holloman, G. H. Jr., and Feifel, D. (2012). The psychopharmacology of agitation: consensus statement of the American Association for Emergency Psychiatry Project BETA Psychopharmacology Workgroup. West J Emerg Med. 13, 26–34.Google Scholar

Zeller, S. L. (2010). Treatment of psychiatric patients in emergency settings. Prim Psychiatry. 17, 35–41.Google Scholar

Zeller, S. L. (2012). New guidelines shake up treatment of agitation. Psychiatric Times. March 27. Available at: http://www.psychiatrictimes.com/psychiatric-emergencies/new-guidelines-shake-treatment-agitation (Accessed May 30, 2016).Google Scholar

Zeller, S.L. and Citrome, L. (2016). Managing agitation associated with schizophrenia and bipolar disorder in the emergency setting. West J Emerg Med. 17, 165–172.Google Scholar

Zeller, S.L. and Rhoades, R.W. (2010). Systematic reviews of assessment measures and pharmacologic treatments for agitation. Clin Ther. 32, 403–425.CrossRefGoogle ScholarPubMed